A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
AstraZeneca PLC Dữ liệu về giá theo thời gian thực
The current price of AstraZeneca PLC in the market is 2.250.866,92 ₫, with a 24-hour trading volume of 63,31B ₫. The asset's market cap is 6,97P ₫, after moving 0.06% in the last day.
Tokenized AstraZeneca PLC is trading at 2.252.201,14 ₫, with a tokenized market cap of 16,89B ₫ and a 24-hour trading volume of 2,12B ₫. The tokenized asset has moved -1.29% in the past 24 hours.